from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3583c/-

LFCtreatmentdescriptionclass of inhibitor

1.054

Amikacinug/mL Amikacintranslation

-0.306

Cap5-10ug/mL Capreomycintranslation

0.457

Rox10-50 ug/mL Roxithromycintranslation

1.115

SM2-5 ug/mL Streptomycintranslation

0.866

Tet5-10 ug/mL Tetracyclinetranslation

-3.171

Rif0.2-5ug/mL Rifampicintranscription

-1.254

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.808

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.181

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.063

CPZ10-50 ug/mL Chlorpromazinerespiration

0.165

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.006

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.368

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.888

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.294

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.005

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.661

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.008

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.055

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.074

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.494

KCN5-20 ug/mL Potassium cyaniderespiration

0.392

NaN30.2-2 mM Sodium aziderespiration

-0.582

Nigericin50 uM Nigericinrespiration

0.926

TRC10-150 ug/mL Triclosanrespiration

-1.062

TRZ10-25 ug/mL Thioridazinerespiration

0.715

Valinomycin0.5-10 uM Valinomycinrespiration

-0.795

ZnSO42 mM ZnSO4respiration

-0.456

menadione6-10 ug/mL Menadionerespiration

0.024

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.087

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.055

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.094

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.195

NRP_1Non-replicating persistence stage 1dosRassociated

0.473

Amp0.2mg/mL AmpicillincellWall

-0.398

Cephalexin20-100 ug/mL CephalexincellWall

-0.548

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.267

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.520

EMB10-20 ug/mL EthambutolcellWall

-0.014

Eta12-40 ug/mL EthionamidecellWall

0.514

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.050

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.505

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.701

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.792

BZA0.12 mg/mL BenzamidearomaticAmides

1.361

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.968

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.363

H2O24 mM hydrogen peroxideDNAdamaging

0.479

Levo10 ug/mL LevofloxacinDNAdamaging

-0.227

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.764

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.780

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.343

UVUV-irradiationDNAdamaging

-1.580

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.729

Antimycin12.5-50 ug/mL Antimycin A?

-0.554

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.471

PA_110-50 ug/mL Antitubercular compound PA-1?

0.182

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.003

PA8240.2-2 ug/mL PA-824?

0.325

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.095

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.414

Verapamil50 uM Verapamil?

-0.314

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.705

methoxatin10-20 ug/mL Methoxatin?